HRT Financial’s ESSA Pharma EPIX Stock Holding History

HRT Financial’s Portfolio EPIX Stock Details EPIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-53,443	Closed	-$168K	–	2994
2022 Q2	$168K	Buy	+53,443	New	+$299K	﹤0.01%	2299
2021 Q4	–	Sell	-74,187	Closed	-$593K	–	3401
2021 Q3	$593K	Buy	+74,187	New	+$1.18M	﹤0.01%	1832
2021 Q2	–	Sell	-24,616	Closed	-$715K	–	3013
2021 Q1	$715K	Buy	+24,616	New	+$572K	0.01%	1513

Other funds holding EPIX

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

RPAM

Rhenman & Partners Asset Management Stockholm, Sweden $1.06B AUM 52.03% 1-Year Est. Return

HRT Financial's EPIX Position: Q3 2022 in Review

HRT Financial sold out of ESSA Pharma (EPIX) in Q3 2022, closing a stake of 53,443 shares — an estimated $168K sold.

HRT Financial first reported a position in EPIX in Q1 2021 and held it in 3 quarters. The position peaked at $715K in Q1 2021. 54 funds tracked by Wall St. Rank hold EPIX as of Q3 2022.

HRT Financial reported no remaining ESSA Pharma position as of Q3 2022 after selling out during the quarter.
HRT Financial sold 53,443 ESSA Pharma shares in Q3 2022, an estimated $168K.
HRT Financial first reported a position in ESSA Pharma in Q1 2021 and held it in 3 quarters.
HRT Financial's ESSA Pharma position peaked at $715K in Q1 2021.
54 funds tracked by Wall St. Rank held ESSA Pharma as of Q3 2022.

Based on HRT Financial's 13F filing for Q3 2022, filed 14 Nov 2022.